期刊文献+

Integration of genome scale data for identifying newplayers in colorectal cancer

Integration of genome scale data for identifying new players in colorectal cancer
下载PDF
导出
摘要 Colorectal cancers(CRCs) display a wide variety of genomic aberrations that may be either causally linked to their development and progression, or might serve as biomarkers for their presence. Recent advances in rapid high-throughput genetic and genomic analysis have helped to identify a plethora of alterations that can potentially serve as new cancer biomarkers, and thus help to improve CRC diagnosis, prognosis, and treatment. Each distinct data type(copy number variations, gene and micro RNAs expression, Cp G island methylation) provides an investigator with a different, partially independent, and complementary view of the entire genome. However, elucidation of gene function will require more information than can be provided by analyzing a single type of data. The integration of knowledge obtained from different sources is becoming increasingly essential for obtaining an interdisciplinary view of large amounts of information, and also for cross-validating experimental results. The integration of numerous types of genetic and genomic data derived from public sources, and via the use of ad-hoc bioinformatics tools and statistical methods facilitates the discovery and validation of novel, informative biomarkers. This combinatory approach will also enable researchers to more accurately and comprehensively understand the associations between different biologic pathways, mechanisms, and phenomena, and gain new insights into the etiology of CRC. Colorectal cancers(CRCs) display a wide variety of genomic aberrations that may be either causally linked to their development and progression, or might serve as biomarkers for their presence. Recent advances in rapid high-throughput genetic and genomic analysis have helped to identify a plethora of alterations that can potentially serve as new cancer biomarkers, and thus help to improve CRC diagnosis, prognosis, and treatment. Each distinct data type(copy number variations, gene and micro RNAs expression, Cp G island methylation) provides an investigator with a different, partially independent, and complementary view of the entire genome. However, elucidation of gene function will require more information than can be provided by analyzing a single type of data. The integration of knowledge obtained from different sources is becoming increasingly essential for obtaining an interdisciplinary view of large amounts of information, and also for cross-validating experimental results. The integration of numerous types of genetic and genomic data derived from public sources, and via the use of ad-hoc bioinformatics tools and statistical methods facilitates the discovery and validation of novel, informative biomarkers. This combinatory approach will also enable researchers to more accurately and comprehensively understand the associations between different biologic pathways, mechanisms, and phenomena, and gain new insights into the etiology of CRC.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第2期534-545,共12页 世界胃肠病学杂志(英文版)
基金 Supported by Associazione Italiana per la Ricerca sul Cancro Grants No.10529 and No.12162 funds obtained throughan Italian law that allows taxpayers to allocate 0.5%share of theirincome tax contribution to a research institution of their choice
关键词 COLORECTAL cancer COPY number VARIATIONS Gene EXPRESSION miRNA EXPRESSION Methylome Dataintegration Colorectal cancer Copy number variations Gene expression mi RNA expression Methylome Data integration
  • 相关文献

参考文献74

  • 1Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI:10.1002/ijc.25516].
  • 2Fearon ER, Vogelstein B. A genetic model for colorectaltumorigenesis. Cell 1990; 61: 759-767 [PMID: 2188735].
  • 3Grady WM. Genomic instability and colon cancer. CancerMetastasis Rev 2004; 23: 11-27 [PMID: 15000146].
  • 4Boland CR, Goel A. Microsatellite instability in colorectal cancer.Gastroenterology 2010; 138: 2073-2087.e3 [PMID: 20420947DOI: 10.1053/j.gastro.2009.12.064].
  • 5Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, IssaJP. CpG island methylator phenotype in colorectal cancer. ProcNatl Acad Sci USA 1999; 96: 8681-8686 [PMID: 10411935].
  • 6Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358:1148-1159 [PMID: 18337604 DOI: 10.1056/NEJMra072067].
  • 7Sj-blom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD,Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, BuckhaultsP, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, WillsonJK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, ParkBH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW,Velculescu VE. The consensus coding sequences of human breastand colorectal cancers. Science 2006; 314: 268-274 [PMID:16959974 DOI: 10.1126/science.1133427].
  • 8Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, DiazLA, Kinzler KW. Cancer genome landscapes. Science 2013; 339:1546-1558 [PMID: 23539594 DOI: 10.1126/science.1235122].
  • 9Wood LD, Parsons DW, Jones S, Lin J, Sj-blom T, Leary RJ,Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z,Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA,Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, ShipitsinM, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL,Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, SuhE, Papadopoulos N, Buckhaults P, Markowitz SD, ParmigianiG, Kinzler KW, Velculescu VE, Vogelstein B. The genomiclandscapes of human breast and colorectal cancers. Science 2007;318: 1108-1113 [PMID: 17932254 DOI: 10.1126/science.1145720].
  • 10Batista PJ, Chang HY. Long noncoding RNAs: cellular addresscodes in development and disease. Cell 2013; 152: 1298-1307[PMID: 23498938 DOI: 10.1016/j.cell.2013.02.012].

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部